India’s First Doha Case: Has Nepal Issued a Notitication?
Pursuant to our posts on the Natco’s application for a Doha Style Compulsory license to export two anti-cancer drugs patented by Roche/Pfizer, there have been some articles on this theme in the mainstream media. We bring you two of them in this post. For our earlier posts, see here (in particular see the exchange with Tahir Amin in the “comments” section of the blog post), and here. Tatum Anderson wrote a piece in IP Watch and Jonathan Allen reports on […]
India’s First Doha Case: Has Nepal Issued a Notitication? Read More »